Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 97 to 99 of 99 entries
Sorted by: Best Match Show Resources per page
Hypercoagulability Testing and Hypercoagulable Disorders in Young Central Retinal Vein Occlusion Patients.

Ophthalmology. Retina

Tauqeer Z, Bracha P, McGeehan B, VanderBeek BL.
PMID: 33774219
Ophthalmol Retina. 2021 Mar 24; doi: 10.1016/j.oret.2021.03.009. Epub 2021 Mar 24.

PURPOSE: To determine frequency of hypercoagulability testing and hypercoagulable states in patients with central retinal vein occlusion (CRVO) younger than 50 years.DESIGN: Retrospective cohort study.PARTICIPANTS: Deidentified patients younger than 50 years with newly diagnosed CRVO from a national insurance...

Cite
Tauqeer Z, Bracha P, McGeehan B, et al. Hypercoagulability Testing and Hypercoagulable Disorders in Young Central Retinal Vein Occlusion Patients. Ophthalmol Retina. 2021;doi: 10.1016/j.oret.2021.03.009.
Tauqeer, Z., Bracha, P., McGeehan, B., & VanderBeek, B. L. (2021). Hypercoagulability Testing and Hypercoagulable Disorders in Young Central Retinal Vein Occlusion Patients. Ophthalmology. Retina, . https://doi.org/10.1016/j.oret.2021.03.009
Tauqeer, Zujaja, et al. "Hypercoagulability Testing and Hypercoagulable Disorders in Young Central Retinal Vein Occlusion Patients." Ophthalmology. Retina vol. (2021). doi: https://doi.org/10.1016/j.oret.2021.03.009
Tauqeer Z, Bracha P, McGeehan B, VanderBeek BL. Hypercoagulability Testing and Hypercoagulable Disorders in Young Central Retinal Vein Occlusion Patients. Ophthalmol Retina. 2021 Mar 24; doi: 10.1016/j.oret.2021.03.009. Epub 2021 Mar 24. PMID: 33774219; PMCID: PMC8460678.
Copy Download .nbib Format: NLM
Utility of Ultrasound and Optical Coherence Tomography in Differentiating Between Papilledema and Pseudopapilledema in Children.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

Farazdaghi MK, Trimboli-Heidler C, Liu GT, Garcia A, Ying GS, Avery RA.
PMID: 33870950
J Neuroophthalmol. 2021 Dec 01;41(4):488-495. doi: 10.1097/WNO.0000000000001248.

BACKGROUND: Differentiating between papilledema and pseudopapilledema in children presenting with mild-to-moderate optic nerve head elevation is challenging. This study sought to determine which B-scan ultrasonography (BSUS) and optical coherence tomography (OCT) features, individually or in combination, are best able...

Cite
Farazdaghi MK, Trimboli-Heidler C, Liu GT, et al. Utility of Ultrasound and Optical Coherence Tomography in Differentiating Between Papilledema and Pseudopapilledema in Children. J Neuroophthalmol. 2021;41(4):488-495doi: 10.1097/WNO.0000000000001248.
Farazdaghi, M. K., Trimboli-Heidler, C., Liu, G. T., Garcia, A., Ying, G. S., & Avery, R. A. (2021). Utility of Ultrasound and Optical Coherence Tomography in Differentiating Between Papilledema and Pseudopapilledema in Children. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 41(4), 488-495. https://doi.org/10.1097/WNO.0000000000001248
Farazdaghi, Marybeth K, et al. "Utility of Ultrasound and Optical Coherence Tomography in Differentiating Between Papilledema and Pseudopapilledema in Children." Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society vol. 41,4 (2021): 488-495. doi: https://doi.org/10.1097/WNO.0000000000001248
Farazdaghi MK, Trimboli-Heidler C, Liu GT, Garcia A, Ying GS, Avery RA. Utility of Ultrasound and Optical Coherence Tomography in Differentiating Between Papilledema and Pseudopapilledema in Children. J Neuroophthalmol. 2021 Dec 01;41(4):488-495. doi: 10.1097/WNO.0000000000001248. PMID: 33870950; PMCID: PMC8514567.
Copy Download .nbib Format: NLM
Risk of non-infectious uveitis or myasthenia gravis in patients on checkpoint inhibitors in a large healthcare claims database.

The British journal of ophthalmology

Xia T, Brucker AJ, McGeehan B, VanderBeek BL.
PMID: 33087313
Br J Ophthalmol. 2022 Jan;106(1):87-90. doi: 10.1136/bjophthalmol-2020-317060. Epub 2020 Oct 21.

AIM: To determine if checkpoint inhibitors (CPIs) confer an increased risk of non-infectious uveitis or myasthenia gravis (MG) compared to patients on non-checkpoint inhibitor (N-CPI) chemotherapy.METHODS: A retrospective cohort study was performed comparing patients in a large commercial and...

Cite
Xia T, Brucker AJ, McGeehan B, et al. Risk of non-infectious uveitis or myasthenia gravis in patients on checkpoint inhibitors in a large healthcare claims database. Br J Ophthalmol. 2020;106(1):87-90doi: 10.1136/bjophthalmol-2020-317060.
Xia, T., Brucker, A. J., McGeehan, B., & VanderBeek, B. L. (2022). Risk of non-infectious uveitis or myasthenia gravis in patients on checkpoint inhibitors in a large healthcare claims database. The British journal of ophthalmology, 106(1), 87-90. https://doi.org/10.1136/bjophthalmol-2020-317060
Xia, Tian, et al. "Risk of non-infectious uveitis or myasthenia gravis in patients on checkpoint inhibitors in a large healthcare claims database." The British journal of ophthalmology vol. 106,1 (2022): 87-90. doi: https://doi.org/10.1136/bjophthalmol-2020-317060
Xia T, Brucker AJ, McGeehan B, VanderBeek BL. Risk of non-infectious uveitis or myasthenia gravis in patients on checkpoint inhibitors in a large healthcare claims database. Br J Ophthalmol. 2022 Jan;106(1):87-90. doi: 10.1136/bjophthalmol-2020-317060. Epub 2020 Oct 21. PMID: 33087313; PMCID: PMC8173351.
Copy Download .nbib Format: NLM
Showing 97 to 99 of 99 entries